Vascular Diseases: Clinical Trials

394 trials for Vascular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

394 unknown. 394 Phase 1, 176 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1394Unknown 394
Phase 2176Unknown 176

Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases

Trials (filtered) newest first · largest first

All 394 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG
Normal saline, Dexmedetomidine, Methylprednisolone - Coronary Artery Disease, Systemic Inflammatory Response Syndrome
Phase 1 / Phase 2UnknownAin Shams University602025-09-012025-08-06
Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke
BOOST GAIT Program - Stroke with Hemiparesis, Stroke
Phase 1UnknownHasselt University122024-09-022024-09-25
Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating Acute Ischemic Stroke
mesenchymal stem cells (umbilical cord) injection - Acute Ischemic Stroke
Phase 1UnknownNational Engineering Center of Cell Products182024-08-012024-07-25
Effect of Single-versus Double-limb Cycling Exercise on Blood Flow in Patients With Peripheral Artery Disease
Cycle - Peripheral Arterial Disease
Phase 1 / Phase 2UnknownCairo University752024-07-012024-07-24
Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer
Allogeneic mesenchymal stem cells (MSCs), Normal Saline - Diabetic Foot Ulcer
Phase 1 / Phase 2UnknownSupergenics Life Science Sdn. Bhd.222024-05-012024-03-06
Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma
Anti-BCMA CAR-NK - Multiple Myeloma, Refractory
Phase 1 / Phase 2UnknownShahid Beheshti University of Medical Sciences102024-04-302024-03-06
Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B
HUC2-565-A, HUC2-565-A and HUC2-565-B, HUC2-565-B, HUC2-565-A and HUC2-565-B - Hypertension
Phase 1UnknownHuons Co., Ltd.462024-04-202024-10-01
Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia
EPCs, Clinical standard treatment (CST) - Critical Limb Ischemia
Phase 1UnknownAllife Medical Science and Technology Co., Ltd.272024-04-012024-04-11
A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma
CM313 injection - Multiple Myeloma
Phase 1 / Phase 2UnknownKeymed Biosciences Co.Ltd1202024-02-282023-11-13
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414
DA414 Granules, DA414 placebo - Ischemic Stroke
Phase 1UnknownChendu DIAO Nine Hong Pharmaceutical Factory822024-02-062024-07-29
Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
Vibrotactile Stimulation - Stroke
Phase 1UnknownUniversity of Colorado, Denver242024-02-022024-04-11
A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma
KQ-2003 CAR T-cells - Multiple Myeloma
Phase 1 / Phase 2UnknownNovatim Immune Therapeutics (Zhejiang) Co., Ltd.292024-01-112024-01-25
Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh: The Dinajpur Study
Multicomponent decentralized care, mHealth - Hypertension, Diabetes
Phase 1UnknownBRAC University67502024-01-012024-02-14
Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for
intra-arterial infusion albumin, mechanical thrombectomy and a standard clinical therapy - Acute Ischemic Stroke
Phase 1UnknownTianjin Huanhu Hospital462023-11-012023-12-15
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
CD19-CAR-DNT cells - Systemic Lupus Erythematosus, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase 1UnknownRenJi Hospital482023-10-302024-03-18
Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage
Fingolimod - Intracerebral Hemorrhage
Phase 1 / Phase 2UnknownTang-Du Hospital402023-10-112023-10-18
A Trial of HRS-7450 in Chinese Healthy Volunteers
HRS-7450 ;Placebo - Cerebral Stroke
Phase 1UnknownFujian Shengdi Pharmaceutical Co., Ltd.502023-10-012023-10-17
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
CD19 targeted CAR-T cells - SLE (Systemic Lupus), Sjogren's Syndrome
Phase 1UnknownChongqing Precision Biotech Co., Ltd242023-08-312023-09-28
Clinical Trial With Adipose Tissue Stem Cells on Biological Matrix for the Treatment of Venous Ulcer of the Lower Limbs
Bioengineered Artificial Mesenchimal Sheet (BAMS), Standard treatment (Control) - Venous Ulcer
Phase 1 / Phase 2UnknownAndalusian Network for Design and Translation of Advanced Therapies202023-07-122023-07-27
Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
Pazopanib - Hereditary Hemorrhagic Telangiectasia, Epistaxis
Phase 1 / Phase 2UnknownCure HHT302023-07-012022-09-08

Showing 20 of 394. Sign in to see all of them.

Narrower conditions

Multiple Myeloma (114)  ·  Stroke (47)  ·  Hypertension (35)  ·  Diabetic Foot (26)  ·  Ischemic Stroke (19)  ·  Recurrence (16)  ·  Myocardial Infarction (15)  ·  Peripheral Arterial Disease (15)  ·  Coronary Artery Disease (14)  ·  Peripheral Vascular Diseases (14)  ·  Chronic Limb-Threatening Ischemia (13)  ·  Heart Failure (13)  ·  Lymphoma (11)  ·  Myocardial Ischemia (11)  ·  Neoplasms, Plasma Cell (11)

Broader conditions

Cardiovascular Diseases (389)  ·  Hemic and Lymphatic Diseases (128)  ·  Immune System Diseases (124)  ·  Pathological Conditions, Signs and Symptoms (124)  ·  Neoplasms by Histologic Type (123)  ·  Hematologic Diseases (121)  ·  Hemorrhagic Disorders (121)  ·  Hemostatic Disorders (121)  ·  Immunoproliferative Disorders (120)  ·  Lymphoproliferative Disorders (119)  ·  Neoplasms (119)  ·  Paraproteinemias (119)  ·  Blood Protein Disorders (118)  ·  Neoplasms, Plasma Cell (110)

Interventions

Dexamethasone (17)  ·  Cyclophosphamide (12)  ·  Sodium Chloride (12)  ·  Saline Solution (9)  ·  Bortezomib (8)  ·  Lenalidomide (8)  ·  fludarabine (7)  ·  pomalidomide (5)  ·  Bendamustine Hydrochloride (4)  ·  Melphalan (4)  ·  Methylprednisolone (4)  ·  Ranibizumab (4)  ·  Aspirin (3)  ·  Clopidogrel (3)  ·  Granulocyte Colony-Stimulating Factor (3)

Sponsors

Chong Kun Dang Pharmaceutical (8)  ·  Capital Medical University (6)  ·  National Taiwan University Hospital (5)  ·  Shanghai 10th People's Hospital (5)  ·  Chinese PLA General Hospital (4)  ·  Hadassah Medical Organization (4)  ·  The First Affiliated Hospital with Nanjing Medical University (4)  ·  Chang Gung Memorial Hospital (3)  ·  China Medical University Hospital (3)  ·  Chongqing Precision Biotech Co., Ltd (3)  ·  Jie Shen (3)  ·  Kessler Foundation (3)  ·  Logan College of Chiropractic (3)  ·  Oncotherapeutics (3)  ·  Peking Union Medical College Hospital (3)

Countries

China (120)  ·  United States (80)  ·  South Korea (22)  ·  Canada (14)  ·  Israel (13)  ·  Taiwan (13)  ·  Germany (11)  ·  Brazil (7)  ·  Netherlands (7)  ·  Russia (7)  ·  Iran (6)  ·  Australia (5)  ·  Egypt (4)  ·  India (4)  ·  Spain (4)

Top investigators

Jie Shen (3)  ·  Barry Oken, MD (2)  ·  Changxi Wang, M.D., Ph.D (2)  ·  Doo-Yeoun Cho, MD (2)  ·  Gang An (2)  ·  James R Berenson, MD (2)  ·  Juan Du, MD (2)  ·  Lugui Qiu (2)  ·  Michael P Murphy, MD (2)  ·  Miles Prince, MD (2)  ·  Suzin Mayerson, PhD (2)  ·  Theodore Leng, MD (2)  ·  Wan-Hong Zhao, MD, PhD (2)  ·  Yifan Zhai, MD, PhD (2)

Results publications

PMID 36100310, PMID 37192741, PMID 37658205, PMID 12473676, PMID 15583741, PMID 15890495, PMID 15978266, PMID 16282547, PMID 16336965, PMID 18468545, PMID 19050436, PMID 19074686, PMID 19099294, PMID 19211094, PMID 19570514, PMID 20097752, PMID 20137879, PMID 20832596, PMID 20966420, PMID 21160056, PMID 21658561, PMID 21911830, PMID 22020113, PMID 22145843, PMID 22457045, PMID 22852051, PMID 23197640, PMID 23278227, PMID 23370205, PMID 23375329, PMID 23670612, PMID 23797811, PMID 23899755, PMID 24523121, PMID 24552184, PMID 24610327, PMID 24650395, PMID 25287762, PMID 25399274, PMID 25530442, PMID 25671797, PMID 25677668, PMID 25908725, PMID 26150318, PMID 26537879, PMID 26584888, PMID 26643677, PMID 27021379, PMID 27053773, PMID 27442600

NIH funding

2019 (3), I01RX000528 (1), R43AG060851 (1), R43NS067694 (1), R44HD065388 (1), R44NS060192 (1), ZIAEB000073 (1)